Advertisements

Steensma, David P.

Ajax Therapeutics, United States

2025 Rank: 11308

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Immunology

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 227 out of 166615 Researchers

Data For The Year: 2025
Metrics Self-Citations Excluded All
Rank Based on Composite Score1130812144
Total Cites14901671
H-index1717
Hm-index77
Number of Single Authored Papers9898
Total Cites to Single Authored Papers8083
Number of Single+First Authored Papers205205
Total Cites to Single+First Authored Papers365384
Number of Single+First+Last Authored Papers332332
Total Cites to Single+First+Last Authored Papers490515
Composite Score33
Number of Distinct Citing Papers11251221
Ratio of Total Citations to Distinct Citing Papers 1.32 1.37
Self-Citation Percentage
10.83%
Found an error in your data? Contact us with your profile link. Contact Us →

Steensma, David P.

Ajax Therapeutics, United States

2024 Rank: 7890

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Immunology

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 186 out of 157372 Researchers

Data For The Year: 2024
Metrics Self-Citations Excluded All
Rank Based on Composite Score78907186
Total Cites16381935
H-index1921
Hm-index78
Number of Single Authored Papers9494
Total Cites to Single Authored Papers99101
Number of Single+First Authored Papers208208
Total Cites to Single+First Authored Papers435467
Number of Single+First+Last Authored Papers333333
Total Cites to Single+First+Last Authored Papers557599
Composite Score33
Number of Distinct Citing Papers11691283
Ratio of Total Citations to Distinct Citing Papers 1.40 1.51
Self-Citation Percentage
15.35%
Found an error in your data? Contact us with your profile link. Contact Us →

Steensma, David P.

Novartis Institutes for BioMedical Research, Inc., United States

2023 Rank: 7916

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Immunology

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 196 out of 147556 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score79166978
Total Cites16061925
H-index1820
Hm-index78
Number of Single Authored Papers9292
Total Cites to Single Authored Papers121122
Number of Single+First Authored Papers201201
Total Cites to Single+First Authored Papers428459
Number of Single+First+Last Authored Papers325325
Total Cites to Single+First+Last Authored Papers552599
Composite Score33
Number of Distinct Citing Papers11741308
Ratio of Total Citations to Distinct Citing Papers 1.37 1.47
Self-Citation Percentage
16.57%
Found an error in your data? Contact us with your profile link. Contact Us →

Steensma, David P.

Novartis Institutes for BioMedical Research, Inc., United States

2022 Rank: 5066

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Immunology

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 147 out of 138599 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score50665005
Total Cites17602007
H-index2123
Hm-index88
Number of Single Authored Papers9292
Total Cites to Single Authored Papers144147
Number of Single+First Authored Papers196196
Total Cites to Single+First Authored Papers477501
Number of Single+First+Last Authored Papers317317
Total Cites to Single+First+Last Authored Papers617652
Composite Score33
Number of Distinct Citing Papers12691378
Ratio of Total Citations to Distinct Citing Papers 1.39 1.46
Self-Citation Percentage
12.31%
Found an error in your data? Contact us with your profile link. Contact Us →

Steensma, David P.

Dana-Farber Cancer Institute, United States

2021 Rank: 5624

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Immunology

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 149 out of 127911 Researchers

Data For The Year: 2021
Metrics Self-Citations Excluded All
Rank Based on Composite Score56245013
Total Cites22362606
H-index2327
Hm-index1111
Number of Single Authored Papers9191
Total Cites to Single Authored Papers226238
Number of Single+First Authored Papers190190
Total Cites to Single+First Authored Papers647691
Number of Single+First+Last Authored Papers310310
Total Cites to Single+First+Last Authored Papers842905
Composite Score33
Number of Distinct Citing Papers16691839
Ratio of Total Citations to Distinct Citing Papers 1.34 1.42
Self-Citation Percentage
14.20%
Found an error in your data? Contact us with your profile link. Contact Us →

Steensma, David P.

Dana-Farber Cancer Institute, United States

2020 Rank: 7770

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Immunology

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 188 out of 108509 Researchers

Data For The Year: 2020
Metrics Self-Citations Excluded All
Rank Based on Composite Score77706718
Total Cites14251730
H-index1720
Hm-index99
Number of Single Authored Papers8888
Total Cites to Single Authored Papers147161
Number of Single+First Authored Papers182182
Total Cites to Single+First Authored Papers457513
Number of Single+First+Last Authored Papers294294
Total Cites to Single+First+Last Authored Papers578654
Composite Score33
Number of Distinct Citing Papers10911237
Ratio of Total Citations to Distinct Citing Papers 1.31 1.40
Self-Citation Percentage
17.63%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements